INSIGHTS ON FACILITY DESIGN

• Vaccines Development, Regulations And Manufacturing Part-2

  In Part 2, we will review vaccine processes with examples based upon influenza vaccine, inactivated Polio vaccine and an overview of the different types of vaccine production processes from cell expansion, USP and DSP, to the formulation and filling operations to make the finished product. We will talk about vaccine production facilities, how equipment is integrated their operating principles and biological safety levels for containment. Finally, we will look at the vaccine industry today, the supply chain and globalization, and how important vaccines are in pandemic preparedness, availability, and time to market.

• Improve Bioprocessing Efficiency With A Standardized Automation Platform

  Designed specifically for the biomanufacturing industry, Cytiva's Figurate automation is a portfolio of automation platform solutions powered by the reliability of Emerson’s DeltaV.

• High-Quality Chromatography System Meets Predesigned DeltaV For Integrated Manufacturing

  Cytiva’s pre-defined automation solution, Figurate™️, is now available as a turnkey solution by combining our industry-leading ÄKTA™️ process chromatography system with the reliability of the DeltaV DCS platform.

• Achieving Business Continuity In Pharma During COVID-19 Restrictions

  To ensure business continuity during COVID-19 restrictions, we developed a virtual factory acceptance testing solution that allowed SaudiVax to advance their manufacturing plan.

• How To Prepare For Future Viral Vector Manufacturing Technologies And Platforms

  3/1/2021

  The challenges and shortage of vector production reflect the fact that these materials and products are having such strong clinical success. Let’s celebrate the reason for this demand. To meet it, we need to industrialize and rethink how we transition from what has historically been carried out in translational clinical centers at smaller scale, using flasks and open systems, towards commercial production and methodologies.

• Effectively Managing Data In Process Development

  1/11/2021

  Addressing data management challenges during drug development requires an understanding of today’s shortcomings and the factors to consider when adopting a solution to overcome them.

• Covid-19 Impact On Bioprocessing: PART 3 Long-Term Changes

  11/6/2020

  Although suppliers have proven themselves rather robust in their dealing with the pandemic and business is continuing generally uninterrupted, there will be significant long-term changes.

• Re-Imagining Vaccine Manufacturing To Address Global Health Challenges

  10/27/2020

  In the last decade, biopharmaceutical industries have mobilized quickly in response to pandemics. Developing vaccines and manufacturing large doses in response to an emergency is often constrained by existing platforms and facility configurations. Learn how vaccine manufacturing can evolve to tackle future global health challenges.

• COVID-19 Impact On Bioprocessing: PART 1 Accelerating Trends

  10/21/2020

  Because of the urgent demand for treatments, vaccines and assays, the pharmaceutical and biotech industries are experiencing disruptive, often chaotic, increased demands on resources.